![CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy Announce Collaborative Project to Focus on Re-Dosing Gene Therapy in Duchenne Muscular Dystrophy | Muscular Dystrophy Association CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy Announce Collaborative Project to Focus on Re-Dosing Gene Therapy in Duchenne Muscular Dystrophy | Muscular Dystrophy Association](https://www.mda.org/sites/default/files/pr/2023/06/MG-Drug-Approval-fb.jpg)
CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy Announce Collaborative Project to Focus on Re-Dosing Gene Therapy in Duchenne Muscular Dystrophy | Muscular Dystrophy Association
![Frontiers | Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics Frontiers | Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics](https://www.frontiersin.org/files/Articles/851491/fcvm-09-851491-HTML/image_m/fcvm-09-851491-g001.jpg)
Frontiers | Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics
![CureDuchenne Launches the CureDuchenne Caregiver Course: A Free Virtual Resource for Duchenne Muscular Dystrophy Caregivers CureDuchenne Launches the CureDuchenne Caregiver Course: A Free Virtual Resource for Duchenne Muscular Dystrophy Caregivers](https://mma.prnewswire.com/media/1178181/CureDuchenne_Logo.jpg?p=twitter)
CureDuchenne Launches the CureDuchenne Caregiver Course: A Free Virtual Resource for Duchenne Muscular Dystrophy Caregivers
![Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy | European Journal of Human Genetics Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy | European Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41431-021-00811-2/MediaObjects/41431_2021_811_Fig1_HTML.png)
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy | European Journal of Human Genetics
![MDA Celebrates FDA Approval of Amondys 45 for Treatment of DMD Amenable to Exon 45 Skipping | Muscular Dystrophy Association MDA Celebrates FDA Approval of Amondys 45 for Treatment of DMD Amenable to Exon 45 Skipping | Muscular Dystrophy Association](https://www.mda.org/sites/default/files/2021/02/2021-DMD-Facebook-Post.jpg)
MDA Celebrates FDA Approval of Amondys 45 for Treatment of DMD Amenable to Exon 45 Skipping | Muscular Dystrophy Association
![Muscular Dystrophy Association Celebrates FDA Approval of Viltolarsen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping | Muscular Dystrophy Association Muscular Dystrophy Association Celebrates FDA Approval of Viltolarsen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping | Muscular Dystrophy Association](https://www.mda.org/sites/default/files/2020/08/8-12-2020-DMD-Facebook-Post.jpg)